HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The novel chelator lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA) promotes stable binding of His-tagged proteins to liposomal membranes: potent anti-tumor responses induced by simultaneously targeting antigen, cytokine and costimulatory signals to T cells.

Abstract
Recent studies indicate that the chelator lipid nitrilotriacetic acid ditetradecylamine (NTA-DTDA) can be used to engraft T cell costimulatory molecules onto tumor cell membranes, potentially circumventing the need for genetic manipulation of the cells for development of cell- or membrane-based tumor vaccines. Here, we show that a related lipid 3(nitrilotriacetic acid)-ditetradecylamine (NTA(3)-DTDA, which has three NTA moieties in its headgroup instead of one) is several-fold more effective than NTA-DTDA at promoting stable His-tagged protein engraftment. IAsys biosensor studies show that binding of His-tagged B7.1 (B7.1-6H) to NTA(3)-DTDA-containing membranes, exhibit a faster on-rate and a slower off-rate, compared to membranes containing NTA-DTDA. Also, NTA(3)-DTDA-containing liposomes and plasma membrane vesicles (PMV) engrafted with B7.1-6H and CD40-6H exhibit greater binding to T cells, in vitro and in vivo. Engrafted NTA(3)-DTDA-containing PMV encapsulated cytokines such as IL-2, IL-12, GM-CSF and IFN-gamma, allowing targeted delivery of both antigen and cytokine to T cells, and stimulation of antigen-specific T cell proliferation and cytotoxicity. Importantly, use of B7.1-CD40-engrafted PMV containing IL-2 and IL-12 as a vaccine in DBA/2J mice induced protection against challenge with syngeneic tumor cells (P815 mammary mastocytoma), and regression of established tumors. The results show that stable protein engraftment onto liposomal membranes using NTA(3)-DTDA can be used to simultaneously target associated antigen, costimulatory molecules and cytokines to T cells in vivo, inducing strong anti-tumor responses and immunotherapeutic effect.
AuthorsChristina L van Broekhoven, Joseph G Altin
JournalBiochimica et biophysica acta (Biochim Biophys Acta) Vol. 1716 Issue 2 Pg. 104-16 (Oct 15 2005) ISSN: 0006-3002 [Print] Netherlands
PMID16225839 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amines
  • Antigens
  • B7-1 Antigen
  • CD40 Antigens
  • Chelating Agents
  • Cytokines
  • Interleukin-2
  • Lipids
  • Liposomes
  • Recombinant Proteins
  • nitrilotriacetic acid ditetradecylamine
  • Interleukin-12
  • Histidine
  • Nitrilotriacetic Acid
Topics
  • Amines (chemistry)
  • Animals
  • Antigens (metabolism)
  • B7-1 Antigen (chemistry)
  • Biosensing Techniques
  • CD40 Antigens (chemistry, metabolism)
  • Cell Membrane (metabolism)
  • Cell Proliferation
  • Chelating Agents (pharmacology)
  • Cytokines (metabolism)
  • Dose-Response Relationship, Drug
  • Female
  • Histidine (chemistry)
  • Interleukin-12 (metabolism)
  • Interleukin-2 (metabolism)
  • Kinetics
  • Lipids
  • Liposomes (chemistry, metabolism)
  • Lymphocyte Activation
  • Male
  • Mice
  • Mice, Inbred DBA
  • Models, Chemical
  • Neoplasm Transplantation
  • Nitrilotriacetic Acid (analogs & derivatives, chemistry)
  • Protein Binding
  • Recombinant Proteins (chemistry)
  • T-Lymphocytes (cytology, metabolism)
  • Temperature
  • Time Factors
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: